Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

Erratum: Author's order correction Comparison of the Effectiveness in the Application of Competitive and Noncompetitive Internal Control for the Laboratory Developed Polymerase Chain Reaction

Kang JW, Shin SM, Kang JW, Seo YI, Min H

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):178-178.
  • doi: 10.17945/kjbt.2019.30.2.178
Corrections of author names are needed.
Experiences of Blood Bank Performance in Brian Allgood Army Community Hospital

Nam PS

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):174-177.
  • doi: 10.17945/kjbt.2019.30.2.174
Brian Allgood Army Community Hospital (BAACH) is one of the US military General Hospitals in Korea that have blood services. The author of this paper is a civilian employee who...
Case of D-Variant from a Frameshift Mutation RHD 711delC

Ma T, Yu H, Jeon S, Cho D, Chun S, Shin MG

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):168-173.
  • doi: 10.17945/kjbt.2019.30.2.168
D antigens are clinically significant, and routine tests on the D antigen requires the inclusion of weak D testing, which is performed using indirect antihuman immunoglobulin methods. On the other...
Investigation of the Association of HCV or HIV Markers in Non-Discriminated Blood Donations

Kang J, Shin S, Kang JW, Seo YI, Min H, Kim M

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):163-167.
  • doi: 10.17945/kjbt.2019.30.2.163
HBV core antibody and surface antibody test are currently conducted for those donors showing non-discriminated reactive (NDR) results on a nucleic acid amplification test (NAT) as a blood donor screening...
Estimation of the Residual Risk of Transfusion-Transmissible Infectious Agents in Korea

Kang JW, Shin S, Seo DH, Kang J, Ko DH, Song CE, Lee MN, Kim JN

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):156-162.
  • doi: 10.17945/kjbt.2019.30.2.156
BACKGROUND: The risk of transfusion-transmissible infections (TTIs) of HBV, HCV, and HIV in Korea has been reduced significantly by strengthening the blood safety policies. On the other hand, the risk...
Risk Factors for Adverse Events of Therapeutic Plasma Exchange Assessed in a Single Center Study

Park CG, Lee AJ, Mun SH, Kim SG, Jeon CH, Suh HS

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):148-155.
  • doi: 10.17945/kjbt.2019.30.2.148
BACKGROUND: Therapeutic plasma exchange (TPE) is used to remove pathologic substances involved in various disease etiologies. The use of TPE is increasing steadily in a variety of disease. This study...
Development of a Transfusion-Indication Data-Entry Program and Analysis of Transfusion Indications at a University Hospital in Korea

Shin WY, Lee JJ, Chung H, Shin JW

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):138-147.
  • doi: 10.17945/kjbt.2019.30.2.138
BACKGROUND: Transfusion guidelines are not only essential for the optimal use of blood products, but also help reduce transfusion-related adverse reactions and improve patients' outcomes. In this hospital, a transfusion-indication...
Molecular Genetic and Serologic Analysis of the O allele in the Korean Population

Lee JY, Song SA, Oh SH

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):124-137.
  • doi: 10.17945/kjbt.2019.30.2.124
BACKGROUND: The recent expansion of knowledge about various ABO alleles has led to the need for a comprehensive measure to cover the numerous polymorphisms dispersed in the ABO gene. A...
Identification of MicroRNA Related to the CD34+ Cell Fraction of Cord Blood Stem Cells

Lee JH, Song EY, Kim N, Roh EY, Park HW, Yoon JH, Shin S

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):113-123.
  • doi: 10.17945/kjbt.2019.30.2.113
BACKGROUND: Cord blood (CB) is a reliable source of hematopoietic stem cells, and its utilization in stem cell transplantation is increasing continuously. The CD34+ cell count is arguably one of...
Alloantibodies to High-Incidence Antigen: Review of Cases and Transfusion Experiences in Korea

Choi SJ, Chung YN, Cho D, Kim S

  • Korean J Blood Transfus.
  • 2019 Aug;30(2):101-112.
  • doi: 10.17945/kjbt.2019.30.2.101
Antibodies to high-incidence red blood cell antigens should be considered if panagglutination reactions are noted in all panel cells, and negative reactions to autologous red blood cells are detected on...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr